Forte Biosciences, Inc.

Symbol: FBRX on Nasdaq
Entity: Company
Industry: Pharmaceutical Preparations (Office Of Life Sciences)
Business address: 3060 Pegasus Park Drive, Building 6, 75247 Dallas, TX
Phone: (310) 618-6994
State of incorporation: DE
Fiscal year end: December 31
Category: Non-accelerated filer
Smaller reporting company
Former names: Tocagen Inc (to 6/15/2020)
All SEC filings: View on sec.gov

Get insider transactions for this issuer

Forte Biosciences, Inc. has filed 550 SEC EDGAR filings since 11/16/2007

Latest Filings

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
8-K	Open Document \| Data	Open Filing	8-K	May 30, 2025	May 29, 2025	001-38052
SCHEDULE 13G/A	Open Document	Open Filing		May 15, 2025		005-89959
10-Q	Open Document \| Data	Open Filing	10-Q	May 15, 2025	Mar 31, 2025	001-38052
8-K	Open Document \| Data	Open Filing	8-K	May 15, 2025	May 15, 2025	001-38052
SCHEDULE 13G/A	Open Document	Open Filing		May 14, 2025		005-89959
ARS	Open Document	Open Filing	ARS	Apr 30, 2025	Dec 31, 2024	001-38052
DEF 14A	Open Document \| Data	Open Filing	DEF 14A	Apr 30, 2025	May 29, 2025	001-38052
8-K	Open Document \| Data	Open Filing	8-K	Apr 18, 2025	Apr 18, 2025	001-38052
8-K	Open Document \| Data	Open Filing	8-K	Apr 4, 2025	Mar 31, 2025	001-38052
EFFECT	Open Document	Open Filing		Apr 3, 2025		333-286226
4	Open Document	Open Filing		Apr 2, 2025	Apr 1, 2025
4	Open Document	Open Filing		Apr 2, 2025	Apr 1, 2025
CORRESP	Open Document	Open Filing		Apr 1, 2025
UPLOAD	Open Document	Open Filing		Apr 1, 2025		333-286226
S-3	Open Document	Open Filing	S-3	Mar 28, 2025		333-286226
10-K	Open Document \| Data	Open Filing	10-K	Mar 28, 2025	Dec 31, 2024	001-38052
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 20, 2025
4	Open Document	Open Filing		Mar 21, 2025	Mar 19, 2025
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G/A	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G	Open Document	Open Filing		Feb 14, 2025		005-89959
SCHEDULE 13G	Open Document	Open Filing		Feb 13, 2025		005-89959
SCHEDULE 13G/A	Open Document	Open Filing		Feb 10, 2025		005-89959
S-8	Open Document	Open Filing	S-8	Feb 7, 2025		333-284769
8-K	Open Document \| Data	Open Filing	8-K	Jan 24, 2025	Jan 24, 2025	001-38052
SCHEDULE 13G	Open Document	Open Filing		Jan 10, 2025		005-89959
4	Open Document	Open Filing		Jan 2, 2025	Jan 1, 2025
4	Open Document	Open Filing		Jan 2, 2025	Jan 1, 2025
DEF 14A	Open Document	Open Filing	DEF 14A	Dec 31, 2024	Jan 24, 2025	001-38052
EFFECT	Open Document	Open Filing		Dec 20, 2024		333-283814
424B3	Open Document	Open Filing	424B3	Dec 20, 2024		333-283814
CORRESP	Open Document	Open Filing		Dec 18, 2024
UPLOAD	Open Document	Open Filing		Dec 16, 2024		333-283814
S-3	Open Document	Open Filing	S-3	Dec 13, 2024		333-283814
SC 13G/A	Open Document	Open Filing	FORTE BIOSCIENCES, INC.	Dec 6, 2024		005-89959
8-K	Open Document \| Data	Open Filing	8-K	Dec 3, 2024	Dec 3, 2024	001-38052
4	Open Document	Open Filing		Nov 22, 2024	Nov 21, 2024
8-K	Open Document \| Data	Open Filing	8-K	Nov 20, 2024	Nov 19, 2024	001-38052
SC 13G/A	Open Document	Open Filing	SC 13G/A	Nov 14, 2024		005-89959

Previous1 2 3 4 5…11Next

Showing 1 to 50 of 527 entries